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Volume 51, Number 4 Abstracts 1073Conclusions: In multitrauma patients, the presence of a vascular injury
was associated with increased mortality rate compared with nonvascular
trauma patients with similar ISS and RTS. These scoring systems underesti-
mated the mortality rate of patients with vascular trauma.
Surgical Management of Tumors Involving the Aorta and Major
Arterial Structures
SusanneG.Carpenter,MD,aWilliamB. Stone,MD,a ThomasC. Bower,MD,b
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Objectives:This study investigated the surgical management of tumors
arising from or involving the aorta and major arterial structures.
Methods: All patients undergoing arterial resection for tumors involving the
aorta or major vascular structures from January 1992 to May 2009 at a single
institution were reviewed. Patients with tumors abutting arteries without necessi-
tating arterial resection and those involving only venous structures were excluded.
Results: Sixty patients underwent arterial resection for the manage-
ment of neoplasms (Table). The iliac arteries were most commonly resected,
with sarcomatous pathology most commonly observed (39 patients, 65%).
Fourteen patients (23%) required return to the operating room. Mean
follow-up was 16.6 months (range 0-122 months). Thirty-two patients had
1-year follow-up. Among those, 1-year overall survival was 69%, with
disease-free survival of 38%.
Conclusions: Resection of tumors involving the aorta and major
arterial structures provides a reasonable option for treatment but with
significant perioperative morbidity. In selected patients, this aggressive
surgical option should not be overlooked.
Does Topical Wound Oxygen Offer an Improved Outcome Over
Conventional Compression Dressings in the Management of Refrac-
tory Non-healing Venous Ulcers?
Sherif Sultan, MD, FRCS, EBSQ-VASC, Wael Tawfick, MBBCh MRCS,
Western Vascular Institute, Galway, Ireland
Background: Topical wound oxygen (TWO2) proposes an option in
the management of refractory venous ulcers (RVU).
Methods: This was a parallel observational comparative study. Patients
with RVU were managed with TWO2 or conventional compression dress-
ings (CCD) for 12 weeks or until full healing. Patients were followed up at
Table. Summary of mortality based on scoring system
Scoring system
Predicted
mortality based
on literature
Mortality in
VT patients
Mortality in
non-VT
patients P
Combined overall N/A 24% 11.8% .108
RTS 5 19% 26% 2.2% .007
ISS 24 25% 61% 28.6% .04
APACHE II 14 19% 18.2% 0% .007
APACHE, Acute Physiology and Chronic Health Evaluation; ISS, Injury
Severity Scores; RTS, Revised Trauma Scores; VT, vascular trauma.
Table. Outcomes of resection for tumors involving arteria
Arterial structure
No. (%) Path margins free
of tumor(N  60)
Aorta 12 (20) 6/12 (50)
Carotid 6 (10) 6/6 (100)
External/common iliac 16 (27) 12/16 (75)
Internal iliac 18 (30) 15/18 (83)
Superficial femoral 3 (5) 2/3 (66)
Miscellaneous 5 (8) 3/5 (60)NA, Data not available.3-month intervals. The primary end point was the proportion of ulcers
healed at 12 weeks. Secondary end points were time to full healing, percent-
age of reduction in ulcer size, pain reduction, recurrence rates and quality-
adjusted time spent without symptoms of disease and toxicity of treatment
(Q-TWiST).
Results: TWO2 therapy was used to manage 46 ulcers and CCD was
used in 37 ulcers. Demographics and risk factors were similar in both groups.
All ulcers were CEAP C6. The mean reduction in ulcer surface area at 12
weeks was 96% after TWO2 therapy and 61% after CCD therapy. At 12
weeks, 80% of TWO2-managed ulcers were completely healed, compared
with 35% of CCD ulcers (P  .0001). Median time to full healing was 45
days in TWO2 patients and 182 days in CCD patients (P .0001). Reverse
gradient of healing was noted in 32 of the 46 TWO2 ulcers. Nine of 19
methicillin-resistant Staphylococcus aureus (MRSA)-positive ulcers managed
with TWO2 were rendered MRSA-negative after 5 weeks, compared with
none of the 17 MRSA-positive CCD ulcers. The pain score threshold in the
TWO2 patients improved from 8 to 3 by 13 days. After 24 months of
follow-up, 8 of the 13 healed CCD ulcers showed signs of recurrence
compared with none of the 37 healed TWO2 ulcers. No local or systemic
complications occurred in either treatment group. TWO2 patients experi-
enced a significantly improved Q-TWiST.
Conclusions: TWO2 reduces recurrence rates, alleviates pain, and
improves the Q-TWiST. We believe it is a valuable tool in the armamentar-
ium of management of patients with RVU.
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Objectives: Endovascular aortic aneurysm repair (EVAR) has been
shown to decrease perioperative morbidity and mortality compared with
conventional open aneurysm repair. Despite the minimally invasive nature of
EVAR, general or regional anesthesia remains the predominant anesthetic
modality. This study compared the effect of the type of anesthesia (local vs
spinal vs general) on the outcomes after EVAR.
Methods: Consecutive EVAR procedures were selected from our
prospectively maintained database of aneurysmal diseases between 2004 and
2008. Anesthesia options included general anesthesia (GA), regional anes-
thesia (RA), and local anesthesia (LA) at the surgeon’s discretion, although
there was a strong individual surgeon bias toward LA. Patients who required
a conduit were excluded. Patients were monitored clinically, with noninva-
sive vascular hemodynamic laboratory studies, and with computed tomog-
raphy scans at regular 6-month intervals. Analysis of variance and 2 tests
were used for continuous and interval variables, respectively.
Results: Of 529 AAAs treated, GA was used for 366 (69.1%), RA for
44(8.3%), and LA for 119 (22.4%). The differences in distribution of age,
sex, American Society of Anesthesiologist status, and comorbidities among
the three groups were not significant (P .05). Mean duration of anesthesia
and length of postanesthesia care unit PACU stay were significantly lower in
the LA group (P  .041) vs GA (P  .005). There was no significant
difference regarding duration of surgery, amount of blood loss, intensive
care unit stay, and hospitalization among the three groups (P  .05).
Postoperative complications such as pneumonia, bowel ischemia, urinary
retention, and urinary tract infection were higher in the GA group vs the RA
and LA groups.
ctures
Reconstruction Estimated blood loss 30-day mortality
No. (%) Mean (range), L No. (%)
9/12 (75) 2.4 (0.76-6.5) 2/12 (17)
4/6 (66) 0.3 (0.05-0.7) 0/6 (0)
11/16 (69) 5.3 (0.3-25) 0/16 (0)
0/18 (0) 3.6 (0.7-14) 1/18 (6)
2/3 (66) 0.88 (0.45-1.3) 0/3 (0)
4/5 (80) NA 0/5 (0)l stru
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EVAR compared with GA or RA due to its lower duration of anesthesia and a
lower instance of pneumonia, urinary tract infection, and urinary retention.
With LA, the total procedure time is decreased relative to RA or GA.
Variations in the Iliolumbar Vein During the Anterior Approach for
Spinal Procedures
Matthew M. Nalbandian, MD, Jane S. Hoashi, MD, Sameer Kalkotwar,
MD, and Thomas Errico, MD, New York University Langone Medical
Center, New York, NY, USA
Objective:The anterior approach to the lumbar spine has been increas-
ingly used to treat numerous conditions. The iliolumbar vein (ILV) is
especially vulnerable when the L4 and L5 vertebrae are exposed, and its
ligature is recommended to avoid hemorrhage. Anatomic variations of the
ILV have been described in cadaveric studies; to date however, there are no
studies on the presence of anomalous ILV in patients undergoing spinal
surgery. Surgeons should be aware of these anatomic variations to avoid
complications during surgical procedures.
Methods: A retrospective study was performed on 159 patients (51%
men; average age 49.7 years) undergoing anterior spinal surgery by a
single-access surgeon and spine surgeons at two different hospitals. Variables
assessed were preoperative diagnosis at the L4-L5 level (spondylolisthesis,
herniated nucleus pulposus, scoliosis, degenerative disk disease, and steno-
sis), age, gender, comorbidities, surgical history, number of levels exposed,
and ILV description. ILV was classified into missing ILV, one, two, three, or
more than three ILVs. Associations between the variables and the number of
ILVs found were evaluated with 2 analysis.
Results:The ILVwas present in 157 patients (98.7%) and was not seen
in the course the exposure in 2 patients (1.3%). A single ILV was found in
116 patients (73%), and multiple ILVs were found in 25.8%: 27 (17%) had
two ILVs, 11 (6.9%) had three ILVs, and 3 (1.9%) had more than three
ILVs. Men had a higher frequency of multiple (2) veins than women (P
.07). Diagnosis, comorbidity, and pelvic surgical history were not associated
with the number of veins found.
Conclusion:A high frequency of multiple veins was observed when the
spine was exposed during the anterior approach. This knowledge is crucial
and will help surgeons avoid the potentially catastrophic complications of an
avulsion of an unexpected extra vein.
Management of Gastrocnemius and/or Soleal Vein Thrombosis: Is
Anticoagulation Effective?
Faheem Haq, MD, Clifford M. Sales, MD, Cheryl Armstrong, BSN, and
Rami Bustami, PhD, Overlook Hospital, Summit, NJ, USA
Objective: The ideal treatment for hospitalized patients with isolated
gastrocnemius and/or soleal venous thrombosis is unclear. Recommenda-
tions range from watchful waiting to full-dose anticoagulation. This pilot
study examined the effectiveness of practice patterns at a single institution as
measured by progression of thrombus.
Methods: The study included all consecutive in-patients with a duplex
diagnosis of isolated gastrocnemius and/or soleal vein clot (no other throm-
botic segments were identified) and where two consecutive duplex studies
from an Intersocietal Commission for the Accreditation of Vascular Labo-
ratories laboratory were available for review. Two study groups were iden-
tified. The TX group included patients who received anticoagulation treat-
ment with fractionated or unfractionated heparin, heparin substitutes, or
warfarin. The NoTX group included those who did not receive anticoagu-
lant. Demographic, risk factors, comorbidities, length of hospital and inten-
sive care unit stay, ambulatory status, and underlying hypercoagulable states
were recorded. The 2 test was used to compare thrombus progression rate
in the two groups. A multivariate logistic regression model was used to
examine the effect of anticoagulation treatment as well as the demographic
and clinical factors on the risk of progression.
Results: The study included 141 patients, of whom 76 (54%) received
anticoagulation. Progression of venous thrombosis was documented in 43
(30%): 25 of 76 (33%) in the TX group and 18 of 65 (28%) in the NoTX
group (P  .50 by 2 test). Multivariate logistic regression analysis showed
that treatment had no significant effect on outcome (odds ratio, 1.28, 95%
confidence interval, 0.55-3.01, P  .57). Patients with end-stage renal
disease (6%) or cerebrovascular accident (13%) had a significantly higher risk
of progression (P .05). None of the other clinical or demographic factors
were significantly associated with the risk of progression.
Conclusions: The results speak to the lack of efficacy of anticoagula-
tion in the management of gastrocnemius and/or soleal vein thrombosis in
the hospitalized patient. When measured by thrombus progression, treatingthese patients without anticoagulation appears to be equally efficacious to
subjecting them to anticoagulant therapy. A prospective, randomized clini-
cal trial will be an important step in fully addressing this clinical dilemma.
Carotid Artery Stenting for Postcarotid Endarterectomy Restenosis is
Safer than Redo Carotid Endarterectomy and Should be the Procedure
of Choice
Ali F. AbuRahma, MD, Shadi Abu-Halimah, MD, Patrick A. Stone, MD,
StephenM.Hass, MD, Albeir Mousa, MD, Erik Lough, MD, L Scott Dean,
PhD, MBA, Tammi Keiffer, RN, and Mary Emmett, PhD, Robert C. Byrd
Health Sciences Center of West Virginia University, Charleston, WV, USA
Objectives: Carotid artery stenting (CAS) has been advocated as an
alternative to redo surgery for patients with postcarotid endarterectomy
(CEA) restenosis. This study compared early and late clinical outcomes for
both groups.
Methods:This study analyzed 192 patients: 72 had reoperation (group
A), and 120 had CAS for post-CEA stenosis (group B). Patients were
followed up prospectively and had duplex ultrasound studies at 1 month,
and every 6 and 12 months thereafter.
Results:Demographic and clinical characteristics were comparable for
both groups, except for diabetes mellitus and coronary artery disease, which
were significantly higher in group B. Indications for reoperations were
transient ischemic attacks (TIA)/stroke in 72% for group A vs 57% for group
B (P  .0328). Mean follow-up was 33 months (range, 1-86 months) for
group A and 24months (range, 1-78months) for group B (P .0026). The
proportion of early (24 months) CEA restenosis was 51% in group A vs
27% in group B (P  .0013). Perioperative stroke rates were 3% and 1%,
respectively (P .5573). There were no myocardial infarctions or deaths in
either group. Overall perioperative complication rates were 19%, including
14% cranial nerve injury (12% transient and 2% permanent) in group A vs 2%
in group B (P  .0001). Combined early and late stroke rates were 3% for
group A and 2% for group B (P .6347). Stroke-free rates at 1, 2, 3, and 4
years were 97%, 97%, 97%, and 97% for group A and 98%, 98%, 98%, and
98% for group B, respectively (P  .6490). Stroke-free survival rates were
also similar. Freedom from50% restenosis at 1, 2, 3, and 4 years was 98%,
95%, 95%, and 95% for group A vs 95%, 89%, 80%, and 72% for group B (P
.0175). Freedom from 80% restenosis at 1, 2, 3, and 4 years was, respec-
tively, 98%, 97%, 97%, and 97% for group A vs 99%, 96%, 92%, and 87% for
group B (P .2281). Four patients (one TIA) in group B had reintervention
for 80% restenosis.
Conclusions: CAS is as effective, and perhaps safer, than redo CEA.
Extracranial Carotid Artery Aneurysms: Long-term Results of Open
Repair
Joseph J. Ricotta II, MD,MS,a Jarrod R. Daniel, MBBS,a Audra A. Duncan,
MD,a Thomas C. Bower, MD,a Gustavo S. Oderich, MD,a William M.
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Objective: Extracranial carotid artery (ECA) aneurysms are rare, but
the potential risk of rupture or thromboembolism argues for early treatment.
Our goal was to determine complications and long-term outcome of open
surgical repair.
Methods: Clinical data of 27 patients (13 women, 14 men; mean age,
65 years) treated for ECA aneurysm at our institution between 1990 and
2009 were retrospectively reviewed.
Results: The mean ECA aneurysm size was 3.9 cm (range, 1.2-6.5
cm). Etiology in the 27 patients was pseudoaneurysm after prior carotid
surgery (37%), fibromuscular dysplasia (14%), trauma (19%), atherosclerosis
(19%), infection (7%), and Marfan syndrome (4%). The 22 nontraumatic
aneurysms involved the internal carotid artery (ICA), and the 5 traumatic
aneurysms involved the common carotid artery. Pulsatile neck mass was
present in 16 patients (59%), an audible bruit was identified in 12 (44%), and
14 (56%) had a documented preoperative transient ischemic attack or stroke.
Nine patients (33%) presented with concomitant aneurysms, most com-
monly involving the abdominal aorta. All patients underwent elective
open surgical repair, including resection in 22, with interposition bypass
grafting (50%), end-to-end primary repair (23%), or patch angioplasty
(27%); carotid ligation in 3; and aneurysmorrhaphy in 2. There were no
